Chlamydia Screening
The goal of this pilot is to demonstrate the usability of the new specifications (Quality Improvement and Clinical Knowledge or QUICK data model, Clinical Quality Language or CQL), where the standards need improvement, and to provide experiential input on how the specifications will serve future implementations in Electronic Health Record systems. This pilot will be focused on how QUICK and CQL can be successfully tailored to suit the needs of implementers interested in supporting clinical decision support (CDS) and clinical quality measures (CQM) for screening, treatment, and follow-up of chlamydia trachomatis infection in community settings.
Additional benefits of the pilot include:
- Broader visibility into the harmonized standards being developed in HL7
- Ability to leverage initiative resources
- Contribution to unification of the CDS/CQM community
- Recognition as an early adopter
At the conclusion of the pilot, pilot participants will aid an evaluation that will inform further development of the specifications.
The pilot summary plan for the Chlamydia Screening pilot is below.Also please find the results of the Phase III pilot survey. Please contact Johanna.GoderreJones@hhs.gov with questions.
CQF Phases II Pilot SurveyFINALwillthompson.pdf
Co-Coordinator | Ken Kawamoto | kensaku.kawamoto@utah.edu |
Co-Coordinator | Floyd Eisenberg | floyd.eisenberg@esacinc.com |
ONC Lead | Julia Skapik | julia.skapik@hhs.gov |
Standards Development SME | Bryn Rhodes | bryn@databaseconsultinggroup.com |
Project Support | Swapna Bhatia | swapna.bhatia@esacinc.com |
CMS Sponsor | Minet Javellana | minet.javellana@cms.hhs.gov |
Use Case Sub-Team Co-Lead | Julie Scherer | jscherer@motivemi.com |
Use Case Sub-Team Co-Lead | Catherine Staes | catherine.staes@hsc.utah.eduHL7 CDS Work Group Liaison | Howard Strasberg | howard.strasberg@wolterskluwer.com |
HL7 CQI Work Group Liaison | Walter Suarez | walter.g.suarez@kp.org |
Chlamydia Screening Pilot Point of Contact | Johanna Goderre | johanna.goderrejones@hhs.gov |
Ischemic Vascular Disease:
Use of Aspirinor Other Antithrombotic Pilot Point of ContactJulie Schererjscherer@motivemi.com